Dong-A ST Donates 150 Million Won in Pharmaceuticals to Medically Underserved People in Cambodia

[Financial News] Dong-A ST continues to provide medical assistance to medically underserved groups in Cambodia using pharmaceuticals and digital healthcare solutions.
Dong-A ST said on the 11th that it donated prescription drugs worth 150 million won to Hebron Medical Center in Phnom Penh, Cambodia, on the 10th. The donation was part of a pharmaceutical support program that has continued since 2018, and the company increased the amount donated this year.
Alongside pharmaceutical support, the company is also working to roll out a patient monitoring system. Last year, Dong-A ST signed a five-year agreement with Hebron Medical Center to support the wearable patient monitoring platform HiCardi. Under the agreement, it will provide HiCardi Plus and LiveStudio devices worth approximately 100 million won and support medical staff training and follow-up management for five years.
In the second year of the agreement, the company trained local medical staff this year in how to install and operate the devices. HiCardi is a medical device attached to patients that continuously measures biological signals such as electrocardiograms, helping medical staff monitor patients’ conditions on an ongoing basis.
The local distributor has also contributed support. Dong-A ST’s Cambodian distributor has been donating beverages since last year and added a cash donation this year.
Hebron Medical Center, the recipient of the support, is a nonprofit medical institution established in 2007 as a free clinic by its director, Kim Woo-jung. It currently treats approximately 90,000 low-income patients a year. In addition to providing pharmaceuticals and medical equipment, it runs programs including medical care in Korea for invited patients, training medical professionals, and improving local public health.
Meanwhile, Dong-A ST has donated prescription drugs to Cambodia since 2018 and is expanding the regions where it provides overseas medical assistance, including by supporting HiCardi at an MCM medical institution in Ethiopia in 2023.

[email protected] Jung Sang-hee Reporter